These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 36497463)
1. An in silico model of the capturing of magnetic nanoparticles in tumour spheroids in the presence of flow. Wirthl B; Janko C; Lyer S; Schrefler BA; Alexiou C; Wall WA Biomed Microdevices; 2023 Nov; 26(1):1. PubMed ID: 38008813 [TBL] [Abstract][Full Text] [Related]
2. Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality. Pfister F; Dörrie J; Schaft N; Buchele V; Unterweger H; Carnell LR; Schreier P; Stein R; Kubánková M; Guck J; Hackstein H; Alexiou C; Janko C Front Immunol; 2023; 14():1223695. PubMed ID: 37662937 [TBL] [Abstract][Full Text] [Related]
3. Tumor Models and Drug Targeting In Vitro-Where Are We Today? Where Do We Go from Here? Krüger M; Kopp S Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980654 [TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Wahajuddin ; Arora S Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170 [TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticle-based drug delivery for cancer therapy. Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Setup for Determination of Nanoparticle-Mediated Magnetic Cell and Drug Accumulation in Tumor Spheroids under Flow Conditions. Behr J; Carnell LR; Stein R; Pfister F; Friedrich B; Huber C; Lyer S; Band J; Schreiber E; Alexiou C; Janko C Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497463 [TBL] [Abstract][Full Text] [Related]
7. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids. Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393 [TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation. Nguyen K; Nuß B; Mühlberger M; Unterweger H; Friedrich RP; Alexiou C; Janko C Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32796757 [TBL] [Abstract][Full Text] [Related]
9. Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation. Boosz P; Pfister F; Stein R; Friedrich B; Fester L; Band J; Mühlberger M; Schreiber E; Lyer S; Dudziak D; Alexiou C; Janko C Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439296 [TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles. Wang B; Wu W; Lu H; Wang Z; Xin H Front Pharmacol; 2018; 9():1556. PubMed ID: 30723412 [TBL] [Abstract][Full Text] [Related]
12. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system. Tian C; Zheng S; Liu X; Kamei KI J Nanobiotechnology; 2022 Jul; 20(1):338. PubMed ID: 35858898 [TBL] [Abstract][Full Text] [Related]